You are here
Overview of MKIs in the Treatment of Cancer
Speaker and Chair: Markus Peck-Radosavljevic, MD (Austria)
Associate Professor of Medicine
Vice Chair, Department of Gastroenterology & Hepatology
Medizinische Universität Wien
Peck-Radosavljevic: Now it is a great honour for me to introduce the distinguished faculty for this satellite symposium.
Right after a short introduction by myself, Bruno Daniele from Napoli will be talking on the use of MKIs in clinical practice, real-world experience, then Marcia Brose will talk about when to start and sequencing MKIs to maximise patient benefit and then Rodolfo Sacco from Pisa will be talking about assessing treatment effects of MKIs.